对于先进细胞癌的第一线治疗方法的现实世界结果的种族差异
Daniel M Geynisman1, William S John2, Taavy A Miller2
1Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States.
The oncologist
|December 20, 2024
概括
种族少数群体在临床试验中的代表性不足. 这项研究发现,与白人患者相比,患有晚期细胞癌 (aRCC) 的黑人患者在一线治疗中表现较差.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 健康差异 在健康上的差异
背景情况:
- 由于少数民族在临床试验中的历史代表性不足,对晚期细胞癌 (aRCC) 治疗结果的种族差异存在有限的数据.
- 关于aRCC的第一线疗法,包括免疫疗法组合和氨酸激酶抑制剂的真实数据很少.
研究的目的:
- 描述先进细胞癌 (aRCC) 的第一线治疗方法的患者特征和临床结果.
- 调查对aRCC治疗疗效和生存的潜在种族差异.
主要方法:
- 对中等/低风险清洁细胞aRCC.患者的回顾性医疗病历审查.
- 从电子医疗表中通过治疗医生的数据抽象.
主要成果:
- 在346名患者中,非洲裔美国人/黑人患者 (n=78) 与白人患者 (n=268) 相比,基线功能表现较差 (ECOG-PS ≥2) 的比例更高 (37.2%对21.3%).
- 与白人患者相比,非裔美国人/黑人患者的整体应答率和整体生存时间较短,与尼沃卢马布 + 伊皮利马布或潘布罗利祖马布 + 阿克西替尼比患者相比,整体应答率和整体生存时间较短.
结论:
- 调查结果突出了现实世界第一线aRCC治疗结果中的显著种族差异.
- 需要进一步研究更大的样本大小来确认这些差异,并为临床实践提供信息.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.5K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
149
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
149
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
